Evoli S, Kariyawasam N, Nitiss K, Nitiss J, Wereszczynski J
Biophys J. 2024; 123(12):1620-1634.
PMID: 38720465
PMC: 11213992.
DOI: 10.1016/j.bpj.2024.05.004.
Ogrizek M, Janezic M, Valjavec K, Perdih A
J Chem Inf Model. 2022; 62(16):3896-3909.
PMID: 35948041
PMC: 9400105.
DOI: 10.1021/acs.jcim.2c00303.
Henderson S, Stevenson C, Malone B, Zholnerovych Y, Mitchenall L, Pichowicz M
J Antimicrob Chemother. 2020; 75(10):2835-2842.
PMID: 32728686
PMC: 7556816.
DOI: 10.1093/jac/dkaa286.
Mader S, Lopez A, Lawatscheck J, Luo Q, Rutz D, Gamiz-Hernandez A
Nat Commun. 2020; 11(1):1410.
PMID: 32179743
PMC: 7075974.
DOI: 10.1038/s41467-020-15050-0.
Klostermeier D
Int J Mol Sci. 2018; 19(5).
PMID: 29772727
PMC: 5983639.
DOI: 10.3390/ijms19051489.
The role of monovalent cations in the ATPase reaction of DNA gyrase.
Hearnshaw S, Chung T, Stevenson C, Maxwell A, Lawson D
Acta Crystallogr D Biol Crystallogr. 2015; 71(Pt 4):996-1005.
PMID: 25849408
PMC: 4388272.
DOI: 10.1107/S1399004715002916.
Identification of inhibitors of Plasmodium falciparum RuvB1 helicase using biochemical assays.
Ahmad M, Tarique M, Afrin F, Tuteja N, Tuteja R
Protoplasma. 2014; 252(1):117-25.
PMID: 24934654
DOI: 10.1007/s00709-014-0664-6.
Structural insight into the PTS sugar transporter EIIC.
McCoy J, Levin E, Zhou M
Biochim Biophys Acta. 2014; 1850(3):577-85.
PMID: 24657490
PMC: 4169766.
DOI: 10.1016/j.bbagen.2014.03.013.
LVIS553 transcriptional regulator specifically recognizes novobiocin as an effector molecule.
Pagliai F, Gardner C, Pande S, Lorca G
J Biol Chem. 2010; 285(22):16921-30.
PMID: 20308066
PMC: 2878039.
DOI: 10.1074/jbc.M110.111138.
The DNA-gate of Bacillus subtilis gyrase is predominantly in the closed conformation during the DNA supercoiling reaction.
Gubaev A, Hilbert M, Klostermeier D
Proc Natl Acad Sci U S A. 2009; 106(32):13278-83.
PMID: 19666507
PMC: 2726392.
DOI: 10.1073/pnas.0902493106.
Spatially and kinetically resolved changes in the conformational dynamics of the Hsp90 chaperone machine.
Graf C, Stankiewicz M, Kramer G, Mayer M
EMBO J. 2009; 28(5):602-13.
PMID: 19165152
PMC: 2657576.
DOI: 10.1038/emboj.2008.306.
Structural frameworks for considering microbial protein- and nucleic acid-dependent motor ATPases.
Thomsen N, Berger J
Mol Microbiol. 2008; 69(5):1071-90.
PMID: 18647240
PMC: 2538554.
DOI: 10.1111/j.1365-2958.2008.06364.x.
Molecular cloning of apicoplast-targeted Plasmodium falciparum DNA gyrase genes: unique intrinsic ATPase activity and ATP-independent dimerization of PfGyrB subunit.
Dar M, Sharma A, Mondal N, Dhar S
Eukaryot Cell. 2007; 6(3):398-412.
PMID: 17220464
PMC: 1828931.
DOI: 10.1128/EC.00357-06.
The key DNA-binding residues in the C-terminal domain of Mycobacterium tuberculosis DNA gyrase A subunit (GyrA).
Huang Y, Deng J, Gu J, Zhang Z, Maxwell A, Bi L
Nucleic Acids Res. 2006; 34(19):5650-9.
PMID: 17038336
PMC: 1636481.
DOI: 10.1093/nar/gkl695.
mAMSA resistant human topoisomerase IIbeta mutation G465D has reduced ATP hydrolysis activity.
Gilroy K, Leontiou C, Padget K, Lakey J, Austin C
Nucleic Acids Res. 2006; 34(5):1597-607.
PMID: 16549872
PMC: 1405819.
DOI: 10.1093/nar/gkl057.
Crystal structures of Escherichia coli topoisomerase IV ParE subunit (24 and 43 kilodaltons): a single residue dictates differences in novobiocin potency against topoisomerase IV and DNA gyrase.
Bellon S, Parsons J, Wei Y, Hayakawa K, Swenson L, Charifson P
Antimicrob Agents Chemother. 2004; 48(5):1856-64.
PMID: 15105144
PMC: 400558.
DOI: 10.1128/AAC.48.5.1856-1864.2004.
ATP-bound conformation of topoisomerase IV: a possible target for quinolones in Streptococcus pneumoniae.
Sifaoui F, Lamour V, Varon E, Moras D, Gutmann L
J Bacteriol. 2003; 185(20):6137-46.
PMID: 14526026
PMC: 225018.
DOI: 10.1128/JB.185.20.6137-6146.2003.
Active-site residues of Escherichia coli DNA gyrase required in coupling ATP hydrolysis to DNA supercoiling and amino acid substitutions leading to novobiocin resistance.
Gross C, Parsons J, Grossman T, Charifson P, Bellon S, Jernee J
Antimicrob Agents Chemother. 2003; 47(3):1037-46.
PMID: 12604539
PMC: 149296.
DOI: 10.1128/AAC.47.3.1037-1046.2003.
Characterisation of the DNA-dependent ATPase activity of human DNA topoisomerase IIbeta: mutation of Ser165 in the ATPase domain reduces the ATPase activity and abolishes the in vivo complementation ability.
West K, Turnbull R, Willmore E, Lakey J, Austin C
Nucleic Acids Res. 2002; 30(24):5416-24.
PMID: 12490710
PMC: 140051.
DOI: 10.1093/nar/gkf677.
Characterization of the nucleotide-binding capacity and the ATPase activity of the PIP3-binding protein JFC1.
Catz S, Johnson J, Babior B
Proc Natl Acad Sci U S A. 2001; 98(20):11230-5.
PMID: 11553774
PMC: 58712.
DOI: 10.1073/pnas.191369598.